Equity Research Medical Care Facilities

Should You Buy Regional Health Properties, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Regional Health Properties, Inc. (RHEP) carries a solid Quality of Company rating of 6.3/10. Trading at $1.05, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 1 of 1 CirclFi valuation models project upside for Regional Health Properties, Inc. (RHEP) at $1.05 — the model consensus leans bullish, with a Quality Score of 6.3/10 and Value-Trap risk of 24/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 6.3/10 — Moderate — mixed signals
  • Value Trap Risk: 24/100 — Minimal — healthy fundamentals
  • Fair Value Range: $2.06 – $2.06 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

6.3 /10

Moderate — mixed signals

Value Trap Risk

24 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

1 /13
Active Models

Avg. confidence: 45%

What Is the Investment Case for Regional Health Properties, Inc. (RHEP) in 2026?

What Is the Bull Case vs the Bear Case for Regional Health Properties, Inc. (RHEP)?

Bull case versus bear case for Regional Health Properties, Inc. (RHEP) at $1.05, derived from 1 active CirclFi valuation models on 2026-10-07.
Bull case — $2.06 target (+96.6%) Bear case
According to the CirclFi Deep Alpha Valuation Engine, 1 of 1 models identify upside from $1.05 to a median fair value of $2.06, indicating the market hasn't fully priced in Regional Health Properties, Inc.'s earnings power. No active model flags significant downside for RHEP. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model targets a fair value of $2.06 (+96.6%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does RHEP Compare to Its Medical Care Facilities Peers?

SGRY Surgery Partners, In
6.4
MCTA Charming Medical Lim
6.1
SRTA Strata Critical Medi
6.5
AIRS AirSculpt Technologi
6.1
CCEL Cryo-Cell Internatio
6.7
CCM Concord Medical Serv
6.0
SNDA Sonida Senior Living
5.1
UHS Universal Health Ser
8.5

Valuation data pages: SGRY · MCTA · SRTA · AIRS · CCEL · CCM · SNDA · UHS · DVA · ADUS · NHC

See full Medical Care Facilities rankings →

Which Other Stocks Score Like RHEP on Quality?

Closest companies to RHEP’s Quality of Company score of 6.3/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on RHEP?

Spread

0%

Fair Value Range

$2.06 – $2.06

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Sentiment SOTP

$2.06 (+96.6%)

Most Bearish

Sentiment SOTP

$2.06 (+96.6%)

What Are the Biggest Risks of Buying RHEP Stock?

Macro/Sector Risk

Medical Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View RHEP Data Page →

So Is Regional Health Properties, Inc. (RHEP) Worth Buying in 2026?

Regional Health Properties, Inc. at $1.05 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 6.3/10, and the median fair value of $2.06 implies +96.6% return potential. Investors should verify this thesis against their own risk parameters and time horizon.

These are quantitative model outputs, not investment recommendations. Regional Health Properties, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About RHEP Stock?

Should I buy RHEP stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for RHEP at $1.05. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Regional Health Properties, Inc.?

Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.

How does RHEP compare to its competitors?

Among Medical Care Facilities peers, RHEP holds a Quality Score of 6.3/10. Comparable companies include SGRY (QOC 6.4), MCTA (QOC 6.1), SRTA (QOC 6.5). The relative ranking helps investors identify whether RHEP offers better fundamental quality than alternatives in the same sector.

Is RHEP a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. RHEP's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy RHEP at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $2.06 to $2.06. At $1.05, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for RHEP.

View RHEP Data Page Full Terminal — $60/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →